Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis

Table 1 Descriptive information regarding the dataset (n = 99)

Characteristic	n (%)
Gender
Male	47 (47)
Female	52 (53)
Ulcerative colitis (UC) duration - scope
New onset	1 (1)
< 1 yr	16 (16)
1-3 yr	30 (30)
3-5 yr	16 (16)
> 5 yr	36 (36)
Indication for procedure
Suspicion of UC	1 (1)
Active symptoms	61 (62)
Consideration of Medication change	10 (10)
Assessment of Medication efficacy	13 (14)
Cancer screening	14 (14)
Paris classification
E1 Proctitis	1 (1)
E2 Left-sided	20 (20)
E3 Extensive	5 (5)
E4 Pancolitis	73 (74)
Medications at time of colonoscopy
5-aminosalicylic acid (5 ASA)	67 (68)
Steroids	30 (30)
Mercaptopurine/methotrexate	33 (33)
Infliximab/adalimumab	12 (12)
Antibiotics	10 (10)
Five ASA Enema	5 (5)
Hydrocortisone Enema	10 (10)
Methotrexate	1 (1)
Tacrolimus	3 (3)
VSL 3 probiotic	10 (10)